Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
9.85
+0.07 (0.72%)
At close: Dec 5, 2025, 4:00 PM EST
9.89
+0.04 (0.41%)
After-hours: Dec 5, 2025, 7:34 PM EST
Telix Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 3,327 | 5,098 | 2,224 | 1,563 | 1,606 | 818 | |
| Market Cap Growth | -32.75% | 129.18% | 42.30% | -2.70% | 96.45% | 196.48% | |
| Enterprise Value | 3,540 | 5,038 | 2,144 | 1,482 | 1,572 | 801 | |
| Last Close Price | 9.85 | 15.40 | - | - | - | - | |
| PE Ratio | 306.76 | 165.02 | 626.21 | - | - | - | |
| PS Ratio | 5.01 | 10.52 | 6.49 | 14.37 | 290.85 | 203.33 | |
| PB Ratio | 7.88 | 14.50 | 21.91 | 28.75 | 1023.78 | 13.41 | |
| P/TBV Ratio | - | 54.17 | 83.14 | 109.40 | - | 53.46 | |
| P/FCF Ratio | 345.20 | 286.95 | 229.72 | - | - | 619.12 | |
| P/OCF Ratio | 147.02 | 191.44 | 136.63 | - | - | 540.78 | |
| EV/Sales Ratio | 5.33 | 10.39 | 6.26 | 13.62 | 284.54 | 199.24 | |
| EV/EBITDA Ratio | 97.24 | 92.95 | 55.00 | - | - | - | |
| EV/EBIT Ratio | 125.99 | 99.41 | 60.60 | - | - | - | |
| EV/FCF Ratio | 367.36 | 283.58 | 221.37 | - | - | 606.68 | |
| Debt / Equity Ratio | 0.99 | 1.02 | 0.12 | 0.13 | 1.18 | 0.03 | |
| Debt / EBITDA Ratio | 10.42 | 6.47 | 0.30 | - | - | - | |
| Debt / FCF Ratio | 43.40 | 20.26 | 1.23 | - | - | 1.29 | |
| Asset Turnover | 0.79 | 0.82 | 1.52 | 0.88 | 0.06 | 0.04 | |
| Inventory Turnover | 10.97 | 10.79 | 15.36 | 10.92 | 1.25 | 3.45 | |
| Quick Ratio | 1.11 | 2.60 | 1.18 | 1.90 | 1.13 | 4.62 | |
| Current Ratio | 1.33 | 2.78 | 1.41 | 2.03 | 1.25 | 4.69 | |
| Return on Equity (ROE) | 3.14% | 13.92% | 4.55% | -253.34% | -198.36% | -60.21% | |
| Return on Assets (ROA) | 2.08% | 5.33% | 9.81% | -25.37% | -37.95% | -23.64% | |
| Return on Capital (ROIC) | 3.12% | 7.78% | 25.26% | -97.35% | -118.20% | -40.13% | |
| Return on Capital Employed (ROCE) | 3.20% | 6.90% | 21.50% | -43.60% | -113.10% | -35.70% | |
| Earnings Yield | 0.33% | 0.61% | 0.16% | -4.53% | -3.64% | -4.23% | |
| FCF Yield | 0.29% | 0.35% | 0.43% | -3.09% | -2.75% | 0.16% | |
| Buyback Yield / Dilution | 37.99% | -6.64% | -4.21% | -10.08% | -9.69% | -10.21% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.